Moderna, Inc. · Q4 2024
ReportedFeb 14, 2025
Period endedDec 31, 2024
Rule of 40−34
The quarter in short
Revenue $966M, down 65.6% year over year and 48.1% on the quarter. EPS −$2.91. Free cash flow $303M, down 24.6% year over year. Rule of 40 score −34.
Reported this quarter
Revenue
$966M
QoQ −48.1%
YoY −65.6%
EPS
−$2.91
QoQ —
YoY —
Free Cash Flow
$303M
QoQ —
YoY −24.6%
Gross Margin
23.5%
QoQ −48.9 pp
YoY −43.5 pp
FCF Margin
31.4%
QoQ +123.6 pp
YoY +17.1 pp
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1682852.
HTML
8-K results announcement
Filed Feb 14, 2025
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
172 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-K annual report
Period ended Dec 31, 2024, filed Feb 21, 2025
ZIP
XBRL data bundle
Structured financial statements from the 10-K
JSON
Company facts (XBRL)
Every figure MRNA has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q4 2024, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings